Skip to Main Content

Our Story in the Media

3 Things to Know About Cobenfy, the New Schizophrenia Drug

“The new drug is promising,” says Vinod Srihari, MD, a Yale Medicine psychiatrist. “But we need to keep in mind that these were five-week studies of a drug to treat an illness that is lifelong, and further studies need to be done to evaluate longer-term impact and side effects.” Dr. Srihari answers questions about Cobenfy, a new schizophrenia drug.

Source: Yale Medicine
Read more
Get RSS Feed